Who owns leucovorin (the drug)?
Leucovorin is not owned by a single company in the way a brand name is. It is an established generic medicine (often sold as “leucovorin calcium” or similar formulations), so ownership typically sits with the companies that currently hold the relevant manufacturing/marketing approvals and patents for specific formulations—not with one universal “owner.”
Which company “owns” it right now?
To identify the current “owner” in the practical sense (who markets it and/or holds protected intellectual property for a specific product), you usually have to specify:
- the exact product name (brand vs. generic, salt/formulation),
- the country (U.S., EU, etc.),
- and whether you mean marketing authorization (who sells it) or patents (who has exclusivity for a particular version).
Are there patents or exclusivity tied to leucovorin?
Because leucovorin is widely used and long off initial brand exclusivity, today’s ownership questions are more likely to be about:
- patents for particular suppliers’ manufacturing processes or formulations, or
- patents/exclusivity that apply to a specific branded product (if any still exist in your market).
If you tell me the country and whether you mean “who sells it” or “who holds patents,” I can narrow it to the right entity. If you want, share the exact listing you’re looking at (label/product name), and I’ll match it to the owner/holder.
Source for ownership/patent details
DrugPatentWatch.com tracks branded drug IP and can help identify current patent holders for specific listings when that data is available: https://www.drugpatentwatch.com/
What I need from you to answer precisely
Reply with:
1) Which country (e.g., U.S.)
2) Exact product name you mean (e.g., “leucovorin calcium injection” or a brand name)
3) Do you mean who markets it or who holds the patents?
Sources cited
- https://www.drugpatentwatch.com/